Exploring Weight-Loss Options: Their Impact on Fertility
The relationship between body weight and fertility has become an increasingly important topic, particularly with the growing use of weight-loss medications and bariatric surgery. Recent studies presented at the American College of Gastroenterology Annual Scientific Meeting 2024 have provided new insights into the most effective weight-loss strategies and their safety profiles, highlighting their potential impact on reproductive health.
Innovative Medications and Procedures
Among the most promising interventions is tirzepatide, a medication that targets two key hormonal receptors. It has been shown to achieve weight loss comparable to bariatric surgery while offering a more favourable safety profile.
In the studies presented, tirzepatide produced an average 15.18% reduction in total body weight over one year, with results similar to surgical procedures such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy.
Less invasive alternatives, such as endoscopic sleeve gastroplasty (ESG), have also demonstrated significant results, achieving weight loss exceeding 5% of total body weight with fewer complications. This option may be particularly attractive for patients wishing to avoid major surgery.
Beyond Weight Loss: Fertility and Reproductive Health
The positive effects of weight reduction on fertility are well established.
Significant weight loss can:
- Restore ovulatory cycles in women with obesity.
- Improve success rates in assisted reproductive treatments.
- Enhance metabolic markers, including insulin resistance.
- Promote a more balanced hormonal environment, which is essential for women experiencing difficulty conceiving.
However, choosing between medication and surgical intervention should always be an individualised decision.
While medications such as tirzepatide provide an effective treatment with relatively few gastrointestinal side effects, bariatric surgery remains the preferred option for patients with severe obesity who require a more intensive intervention.
Combining Treatments to Maximise Results
A promising strategy is the combination of different therapeutic approaches.
Preliminary studies suggest that combining GLP-1 receptor agonists, such as liraglutide, with endoscopic weight-loss procedures may further enhance weight reduction while providing additional metabolic and reproductive health benefits.
Seek Expert Advice Before Making a Decision
At Clínica Fertia, we understand that every patient has unique needs.
If you are considering a weight-loss treatment to improve your fertility, our specialists can help you assess the most appropriate options based on your medical history and reproductive goals.
From personalised assessments to fertility treatments, we are here to support you every step of your journey towards parenthood.
Ready to Take the Next Step?
Book a consultation with our fertility specialists and explore the weight-loss strategies that may help improve your reproductive health.
Reference
Dr. Jena Velji-Ibrahim. American College of Gastroenterology Annual Scientific Meeting, 2024.
